PT1345944E - Processo para o isolamento e purificacao de epotilonas - Google Patents

Processo para o isolamento e purificacao de epotilonas

Info

Publication number
PT1345944E
PT1345944E PT01994791T PT01994791T PT1345944E PT 1345944 E PT1345944 E PT 1345944E PT 01994791 T PT01994791 T PT 01994791T PT 01994791 T PT01994791 T PT 01994791T PT 1345944 E PT1345944 E PT 1345944E
Authority
PT
Portugal
Prior art keywords
epotilonas
isolation
purification
Prior art date
Application number
PT01994791T
Other languages
English (en)
Inventor
Alberto Herminio Maniq Canelas
Ernst Kusters
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT1345944E publication Critical patent/PT1345944E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Silicon Polymers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT01994791T 2000-12-07 2001-12-05 Processo para o isolamento e purificacao de epotilonas PT1345944E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0029895.0A GB0029895D0 (en) 2000-12-07 2000-12-07 Organic compounds

Publications (1)

Publication Number Publication Date
PT1345944E true PT1345944E (pt) 2005-08-31

Family

ID=9904660

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01994791T PT1345944E (pt) 2000-12-07 2001-12-05 Processo para o isolamento e purificacao de epotilonas

Country Status (32)

Country Link
US (2) US6946561B2 (pt)
EP (1) EP1345944B1 (pt)
JP (1) JP4287650B2 (pt)
KR (1) KR100894990B1 (pt)
CN (1) CN1263761C (pt)
AR (1) AR031902A1 (pt)
AT (1) ATE292132T1 (pt)
AU (2) AU2493602A (pt)
BR (1) BR0115991A (pt)
CA (1) CA2433414C (pt)
CZ (1) CZ301664B6 (pt)
DE (1) DE60109814T2 (pt)
DK (1) DK1345944T3 (pt)
EC (1) ECSP034641A (pt)
ES (1) ES2239687T3 (pt)
GB (1) GB0029895D0 (pt)
HK (1) HK1059618A1 (pt)
HU (1) HU224910B1 (pt)
IL (2) IL156088A0 (pt)
MX (1) MXPA03005097A (pt)
MY (1) MY128409A (pt)
NO (1) NO329164B1 (pt)
NZ (1) NZ526197A (pt)
PE (1) PE20020568A1 (pt)
PL (1) PL209406B1 (pt)
PT (1) PT1345944E (pt)
RU (1) RU2285007C2 (pt)
SI (1) SI1345944T1 (pt)
SK (1) SK287356B6 (pt)
TW (1) TWI286137B (pt)
WO (1) WO2002046196A1 (pt)
ZA (1) ZA200304296B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867305B2 (en) 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
JP4579351B2 (ja) * 1996-12-03 2010-11-10 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ エポチロンの合成とその中間体及びその類似物並びにその使用
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
DK1767535T3 (da) * 2002-08-23 2010-04-12 Sloan Kettering Inst Cancer Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
MXPA05003006A (es) * 2002-09-23 2005-06-22 Squibb Bristol Myers Co Metodos para la preparacion, aislamiento y purificacion de epotilona b y estructuras cristalinas de rayos x y de epotilona b.
FR2846520B1 (fr) 2002-11-06 2006-09-29 Roquette Freres Utilisation de maltodextrines branchees comme liants de granulation
KR100681811B1 (ko) * 2005-03-15 2007-02-12 성균관대학교산학협력단 생물학적 대사부산물의 효율적인 제거를 통한 유용 이차대사산물의 제조방법
NZ574194A (en) 2006-08-16 2011-12-22 Novartis Ag Crystal form of epothilone b and use in pharmaceutical compositions
US8906947B2 (en) 2008-02-01 2014-12-09 Zhejiang Hisun Pharmaceutical Co., Ltd. Method for the separation and purification of epothilones
CN105797168A (zh) 2010-05-18 2016-07-27 天蓝制药公司 用于治疗自身免疫性疾病或其它疾病的组合物和方法
KR101372563B1 (ko) * 2011-12-26 2014-03-14 주식회사 삼양바이오팜 에포틸론 함유물질로부터 에포틸론 a와 b의 추출 및 정제 방법
CN110964029B (zh) * 2019-12-19 2020-11-03 鲁南制药集团股份有限公司 一种埃博霉素b发酵液的预处理方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
EP1367057B1 (de) * 1996-11-18 2008-09-17 Gesellschaft für biotechnologische Forschung mbH (GBF) Epothilone E und F
ATE224882T1 (de) * 1997-07-16 2002-10-15 Schering Ag Thiazolderivate, verfahren zur herstellung und verwendung
US6365749B1 (en) * 1997-12-04 2002-04-02 Bristol-Myers Squibb Company Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
DE19826988A1 (de) * 1998-06-18 1999-12-23 Biotechnolog Forschung Gmbh Epothilon-Nebenkomponenten
EP1652926B1 (en) * 2000-04-28 2009-09-30 Kosan Biosciences, Inc. Crystalline epothilone d
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ZA200304296B (en) 2004-04-23
GB0029895D0 (en) 2001-01-24
PE20020568A1 (es) 2002-07-22
WO2002046196A1 (en) 2002-06-13
JP4287650B2 (ja) 2009-07-01
MY128409A (en) 2007-01-31
MXPA03005097A (es) 2003-09-05
JP2004521879A (ja) 2004-07-22
CZ20031565A3 (cs) 2003-10-15
HK1059618A1 (en) 2004-07-09
AU2002224936B2 (en) 2005-09-22
PL361884A1 (en) 2004-10-04
HUP0302579A3 (en) 2004-10-28
IL156088A (en) 2008-08-07
SK6892003A3 (en) 2004-01-08
KR20030053535A (ko) 2003-06-28
NZ526197A (en) 2005-01-28
AU2493602A (en) 2002-06-18
NO329164B1 (no) 2010-09-06
CN1479741A (zh) 2004-03-03
US20040054188A1 (en) 2004-03-18
NO20032591D0 (no) 2003-06-06
CZ301664B6 (cs) 2010-05-19
US20050288514A1 (en) 2005-12-29
EP1345944B1 (en) 2005-03-30
KR100894990B1 (ko) 2009-04-24
ES2239687T3 (es) 2005-10-01
SK287356B6 (sk) 2010-08-09
DE60109814D1 (de) 2005-05-04
EP1345944A1 (en) 2003-09-24
AR031902A1 (es) 2003-10-08
DE60109814T2 (de) 2006-02-16
RU2285007C2 (ru) 2006-10-10
CN1263761C (zh) 2006-07-12
US7569698B2 (en) 2009-08-04
IL156088A0 (en) 2003-12-23
BR0115991A (pt) 2004-01-13
CA2433414C (en) 2011-01-25
ECSP034641A (es) 2003-07-25
CA2433414A1 (en) 2002-06-13
NO20032591L (no) 2003-06-06
PL209406B1 (pl) 2011-08-31
ATE292132T1 (de) 2005-04-15
HU224910B1 (en) 2006-04-28
US6946561B2 (en) 2005-09-20
SI1345944T1 (sl) 2005-12-31
DK1345944T3 (da) 2005-05-30
HUP0302579A2 (hu) 2003-11-28
TWI286137B (en) 2007-09-01

Similar Documents

Publication Publication Date Title
PT1303478E (pt) Processo para a preparacao de alcanoilamidas substituidas
BR9509904A (pt) Processo para purificação e isolamento de 2-desóxi-2,2-difluor-nucleosideos
ATE342323T1 (de) Integriertes hydroisomerizierungs- und alkylierungsverfahren
PT1411789E (pt) Processo e sistema para aumentar o volume do cabelo
BR9802374A (pt) Artigo absorvente e processo de produção para o mesmo
BR0112362B1 (pt) Processo para a preparação de octanoil amidas substituídas e compostos intermediários
DE60139930D1 (de) Desinfizieruns- und desodorierungsverfahren
PT1345944E (pt) Processo para o isolamento e purificacao de epotilonas
IT1317716B1 (it) Processo per la preparazione di perfluoropoliossialchileni conterminali ossidrilici.
PT1147075E (pt) Processo para a preparacao de cloridrato de l-fenilefrina
PT1244702E (pt) Processo para o isolamento da osteopontina do leite
PT1345939E (pt) Processo para a preparacao de imidazotriazinonas substituidas por sulfonamida
PT1432682E (pt) Processo para a preparacao de repaglinida
DE60109229D1 (de) Tupfer
PT102491A (pt) Processo para producao e purificacao de dna plasmidico
PT1292586E (pt) Processo para a preparacao de pirazolopirimidinonas
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
AR028078A1 (es) Proceso para la produccion de grrnulos de enzimas
BR0107826B1 (pt) processo para elaborar poeiras ou misturas de poeiras.
FI20000194A0 (fi) Menetelmä kaupankäynnissä
PT1339723E (pt) Processo e derivados esteres uteis para a preparacao de cefalosporinas
PT1049723E (pt) Processo para o fabrico de inulina de chicoria
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
NO20032769D0 (no) Kombinasjonsmetode for behandling av virale infeksjoner
PT1240173E (pt) Processo para a preparacao de n-fosfonometilglicina